Stay updated on Pembrolizumab Combo in ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in ES-SCLC Clinical Trial page

  1. Check
    8 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1; no changes to page content or layout are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T12:55:26.000Z thumbnail image
  2. Check
    15 days ago
    Change Detected
    Summary
    UI and metadata updates are present, including a 'Show glossary' option, capitalization adjustments for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', and a revision indicator updated to v3.4.0. These changes do not alter core study content, endpoints, or results display.
    Difference
    0.1%
    Check dated 2026-01-29T07:53:48.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T03:16:58.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Locations section updated with numerous new trial sites across the US and internationally, including multiple states and countries. Several previously listed sites have been removed.
    Difference
    2%
    Check dated 2025-12-24T15:11:04.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.2.0 to v3.3.2, indicating a minor metadata update.
    Difference
    0.0%
    Check dated 2025-11-25T14:43:53.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice; no study content or endpoints were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-18T07:24:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.